Search
News
Roswell Park Community Comes Together to Celebrate Outstanding Physicians
… a robotic approach to pancreaticoduodenectomy.” Emese Zsiros, MD, PhD, FACOG — Breaking Barriers Award for Visionary Leadership Dr. Zsiros, Chair of Gynecologic Oncology and the Shashi Lele, … status quo, and leads with clarity and courage. “Dr. Emese Zsiros has a rare and remarkable ability to transform vision …
Blog Post
Does your gut biome affect your response to immunotherapy?
… The study was led by Principal Investigator Emese Zsiros, MD, PhD, FACOG , Chair of Gynecologic Oncology. All … the biological mechanisms behind them,” says Dr. Zsiros. “We observed that patients who experienced a … conditions. In the more immediate future, Drs. Zsiros and Rosario are exploring Dielma fastidiosa, a …
Clinical Trial
Randomized Phase 2 Clinical Trial of Pembrolizumab Combined with Bevacizumab with or without Agonist Anti-CD40 CDX-1140 in Patients with Recurrent Ovarian Cancer
… CDX-1140 in Patients with Recurrent Ovarian Cancer II Zsiros, Emese This phase II trial tests whether pembrolizumab …
Blog Post
Coping with hair loss: Jerrolynn's story
… oncologists Katherine LaVigne Mager, MD, FACOG and Emese Zsiros, MD, PhD, FACOG. “Dr. Mager is a godsend and Dr. Zsiros was my first doctor here and integral in discovering … oncologists Katherine LaVigne Mager, MD, FACOG and Emese Zsiros, MD, PhD, FACOG. “Dr. Mager is a godsend and Dr. …
Department of Immunology Faculty
… Professor of Oncology Department of Immunology Emese Zsiros, MD, PhD, FACOG Professor of Oncology Co-Leader, Tumor …
Clinical Trial
Randomized Phase 2 Trial of APL-2 with Pembrolizumab vs. APL-2 with Pembrolizumab and Bevacizumab vs. Bevacizumab alone in Patients with Recurrent Ovarian Cancer and Persistent Malignant Effusion
… Ovarian Cancer and Persistent Malignant Effusion II Zsiros, Emese This phase II trial studies the effect of APL-2 …
News
Roswell Park Team Demonstrates Safe Approach for Dramatically Reducing Use of Opioids Following Surgery
… patients undergoing surgery, gynecologic oncologist Emese Zsiros, MD, PhD, FACOG , proposed a new pain-management … or recovery at all,” says study Senior Author Dr. Zsiros, Associate Professor of Oncology in the Department of … patients undergoing surgery, gynecologic oncologist Emese Zsiros, MD, PhD, FACOG , proposed a new pain-management …
Tumor Immunology & Immunotherapy Program Members
… Chair, Department of Immunology View the Abrams Lab Emese Zsiros, MD, PhD, FACOG Professor of Oncology Co-Leader, Tumor …
Tumor Immunology & Immunotherapy Research Program
… Chair, Department of Immunology View the Abrams Lab Emese Zsiros, MD, PhD, FACOG Professor of Oncology Co-Leader, Tumor … Trial #: NCT04919629 Principal Investigator: Emese Zsiros, MD, PhD This Phase II trial studies the safety of … Cancer Trial #: NCT05231122 Principal Investigator: Emese Zsiros, MD, PhD This Phase II trial studies the safety and …
Research
Roswell Park-University of Chicago Ovarian Cancer SPORE Faculty and Staff
… Core Roswell Park Comprehensive Cancer Center Emese Zsiros, MD, PhD, FACOG Co-Leader (Clinical), Individual … Core Roswell Park Comprehensive Cancer Center Emese Zsiros, MD, PhD, FACOG Co-Leader (Clinical), Individual …